SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-042097
Filing Date
2024-02-22
Accepted
2024-02-22 07:32:07
Documents
5
Effectiveness Date
2024-02-22

Document Format Files

Seq Description Document Type Size
1 S-8 d781388ds8.htm S-8 36169
2 EX-5.1 d781388dex51.htm EX-5.1 7070
3 EX-23.1 d781388dex231.htm EX-23.1 1745
4 EX-FILING FEES d781388dexfilingfees.htm EX-FILING FEES 20065
5 GRAPHIC g781388g0220222136676.jpg GRAPHIC 2668
  Complete submission text file 0001193125-24-042097.txt   69954
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277242 | Film No.: 24662308
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)